Hydroxyurea Use in Lebanese Patients With [beta]-Thalassemia Intermedia حسب Taher, Ali

"…Other contributing factors may include the differences in the dosages of HU administered, noncompliance with drug therapy, tachyphylaxis to HU effect, the metabolism of the drug, and the small number of patients in our study. Because limited data are available on this subject, more studies in different ethnic groups are required…"
احصل على النص الكامل
احصل على النص الكامل
احصل على النص الكامل